I'd say they want to see how it performs in the US market first. However, whilst earlier acquisitions do often happen, I've seen far more examples of big pharma companies waiting for post-approval before acquiring them. This includes drugs for much more debilitating conditions with little to zero alternative treatment options. Big pharma don't need to take that sort of risk to get a high return, they get the return by taking advantage of their economies of scale for commercialisation etc. So it doesn't make much sense for them to acquire before approval
- Forums
- ASX - By Stock
- BOT
- Sofdra - Post approval royalties, costs and earnings
Sofdra - Post approval royalties, costs and earnings, page-32
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.005(1.33%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 36.0¢ | $2.725M | 7.415M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 70075 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 422900 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 70075 | 0.370 |
5 | 550584 | 0.365 |
4 | 535584 | 0.360 |
13 | 535644 | 0.355 |
28 | 842340 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 372272 | 16 |
0.385 | 278435 | 6 |
0.390 | 921220 | 6 |
0.395 | 624180 | 11 |
0.400 | 1389090 | 28 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online